Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer
about
Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer
description
scientific article published on 06 March 2019
@en
name
Identification and Characteriz ...... use Model of Pancreatic Cancer
@en
type
label
Identification and Characteriz ...... use Model of Pancreatic Cancer
@en
prefLabel
Identification and Characteriz ...... use Model of Pancreatic Cancer
@en
P2093
P1476
Identification and Characteriz ...... use Model of Pancreatic Cancer
@en
P2093
Andrew E Shouksmith
Angelika Berger-Becvar
Ashley A Adile
Chitra Venugopal
David Bakhshinyan
Elvin D de Araujo
Fenil Shah
H Artee Luchman
Justyna M Gawel
Michael W Deininger
P304
P356
10.1021/ACS.JMEDCHEM.8B01957
P577
2019-03-06T00:00:00Z